Biogen (BIIB)

Total Costs & Expenses

$8.68B

TTM · Period ending: · USD

BIIB logo

BIIB Total Costs & Expenses

Latest reported$8.68B
BIIB TTM Total Costs & Expenses ($6.30M → $8.68B)
High-resolution chart · PNG

BIIB total costs & expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Biogen Total Costs & Expenses — Trailing twelve months (TTM) (USD)
Period endingTotal Costs & Expenses (USD)
8,675,600,000
8,315,100,000
7,933,100,000
7,542,500,000
7,590,100,000
7,631,100,000
7,532,800,000
7,461,000,000
7,781,900,000
7,449,800,000
7,738,300,000
7,850,100,000
7,279,100,000
7,165,500,000
7,284,300,000
7,525,500,000
7,866,300,000
8,517,800,000
8,230,500,000
9,186,800,000
9,497,200,000
8,900,100,000
8,894,400,000
7,604,800,000
7,108,900,000
7,062,600,000
7,335,300,000
7,524,900,000
7,472,500,000
7,955,000,000
7,564,300,000
7,321,900,000
7,004,400,000
6,738,500,000
6,928,100,000
7,073,100,000
7,179,700,000
6,736,000,000
6,298,400,000
5,983,700,000
5,859,300,000
5,784,100,000
5,872,700,000
5,682,502,000
5,635,270,000
5,709,497,000
5,730,900,000
5,557,922,000
5,342,303,000
4,975,439,000
4,432,675,000
4,107,724,000
2,389,881,000
2,239,246,000
2,246,251,000
2,180,885,000
3,310,449,000
3,193,055,000
3,057,470,000
3,003,749,000
3,430,433,000
3,449,421,000
3,467,533,000
3,347,325,000
3,102,011,000
3,155,564,000
3,081,919,000
3,082,194,000
3,092,968,000
2,919,240,000
2,883,896,000
2,770,813,000
2,683,720,000
2,553,809,000
2,391,845,000
1,466,734,000
1,312,877,000
1,528,197,000
1,432,165,000
1,557,079,000
1,625,961,000
1,403,238,000
1,477,580,000
1,561,027,000
1,458,424,000
1,439,324,000
1,552,403,000
2,431,744,000
2,026,430,000
1,566,615,000
995,112,000
421,832,000
573,950,000
710,656,000
851,727,000
819,040,000
775,399,000
727,784,000
683,085,000
648,188,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.